A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)
Launched by VIRGINIA CENTER FOR REPRODUCTIVE MEDICINE · Jun 7, 2010
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women between 21-42 undergoing IVF
- Exclusion Criteria:
- • women \> 45,
- • women with one ovary,
- • donor egg,
- • surrogacy,
- • FET cycles,
- • uterine problems,
- • large fibroids
About Virginia Center For Reproductive Medicine
The Virginia Center for Reproductive Medicine (VCRM) is a leading clinical research and treatment facility specializing in reproductive health and fertility preservation. Committed to advancing reproductive medicine through innovative research and clinical trials, VCRM offers state-of-the-art diagnostic and therapeutic services tailored to the unique needs of individuals and couples facing fertility challenges. With a focus on personalized care and cutting-edge technology, VCRM aims to improve patient outcomes and contribute to the scientific understanding of reproductive processes. Their team of experienced specialists is dedicated to providing compassionate support and comprehensive treatment options, fostering hope and achieving family-building goals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reston, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials